Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin

World Journal of Gastroenterology

Volumn 5, Issue 5, 1999, Pages 448-450

  Cui, Hui Fei ^a   Jiang, Xue Liang ^b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Colitis; Corticosteroid resistant; Heparin therapertic use; Ulcerative drug therapy

Indexed keywords

EID: 0000477658     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v5.i5.448     Document Type: Article

References (14)

1. Jiang XL, Quan QZ, Sun ZQ, Wang YJ, Qi F. Effect of glucorticoid on lymphocyte adhesion molecule phenotype expression in patients with ulcerative colitis. Zhongguo Weizhongbing Jijiu Yixue, 1998;10:366 -368
2. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology, 1994;106:840-845
3. Jiang XL, Quan QZ, Liu TT, Wang YJ, Sun ZQ, Qi F, Ren HB, Zhang WL, Zhang L. Detection of platelet activity in ulcerative colitis patients. Xin Xiaohuabingxue Zazhi, 1997;11:736
4. Jiang XL, Quan QZ, Sun ZQ, Wang YJ, Qi F. Relationship between syndrome-typing of ulcerative colitis and activation of platelet. Zhongyi Zazhi, 1997;38:730-731
5. Folwaczny C, Frike H, Endres S, Hartmann G, Jochum M, Loeschke K. Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol, 1997;92:911-912
6. Evans RC, Wong VS, Morris AI, Rhodes JM. Treatment of corticosteroid-resistant ulcerative colitis with heparin: a report of 16 cases. Aliment Pharmacol Ther, 1997;11:1037-1040
7. Gaffney PR, Doyle CT, Gaffney A, Hogen J, Hayes DP, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol, 1995;90:220-223
8. Cui HF, Zhang TM. Studies of oral preparation of low molecular weight heparin. Zhongguo Yaoxue Zazhi, 1995;4:51-52
9. Cui HF, Zhang TM. Studies of oral preparation of low molecular weight heparin from low anticoagulant activity heparin. Zhongguo Sienghua Yauwu Zazhi, 1993;4:10-15
10. Jiang XL, Cui HF, Wang YJ, Quan QZ, Sun ZQ. Effects of oral low molecular weight heparin on hemorrheology of rabbit liver damaged by D-galuctosamine. Xin Xiaohuabingxue Zazhi, 1997;5:355-356
11. Jiang XL, Zhang JZ, Cui HF, Dong ZL, Wang JY. Treatment on acute hepatitis with oral low molecular weight heparin. Xin Xiaohuabingxue Zazhi, 1997;5:296
12. Jiang XL, Quan QZ, Chen GY, Yin GP, Sun ZQ, Wang YJ. Expression of adhesion molecules on tissues and peripheral lymphocytes in patients with ulcerative colitis. Zhonghua Xiaohua Neijing Zazhi, 1998;15:292-294
13. Tyrrell DJ, Kilfeather S, Page CP. Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Tips, 1995;16:198-204
14. Koenigs KP, Mcphedran P, Spiro HM. Thrombosis in inflammatory bowel disease. J Clin Gastroenterol, 1987;9:627-631